Inhibitors of the kynurenine pathway

European Journal of Medicinal Chemistry

Volumn 35, Issue 2, 2000, Pages 179-186

  Stone, Trevor W ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Glutamate; Kynurenic acid; Kynurenines; N methyl D aspartate; Neurodegeneration; Neuroprotection; NMDA; Quinolinic acid; Stroke

Indexed keywords

(3 NITROBENZOYL)ALANINE; 2 METHOXYBENZOYLALANINE; 3 (2 CARBOXY 4,6 DICHLORO 3 INDOLYL)PROPIONIC ACID; 3 PHENYL 4 HYDROXY 7 CHLOROQUINOLINE 2 (1H) ONE; 3,4 DICHLOROBENZOYLALANINE; 3,4 DIMETHOXY N [4 (3 NITROPHENYL) 2 THIAZOLYL]BENZENESULFONAMIDE; 4 CARBOXYMETHYLAMINO 5,7 DICHLORO 2 QUINOLINECARBOXYLIC ACID; 4 HYDROXY 3 (CARBOXYMETHYL)QUINOLINE 2 (1H) ONE; 4 HYDROXY 3 (CYCLOPROPYLCARBONYL) 7 CHLOROQUINOLINE 2 (1H) ONE; 4 [(CARBOXYMETHYL)AMINO] 5,7 DICHLOROQUINOLINE 2 CARBOXYLIC ACID; 5,7 DICHLORO 1,2,3,4 TETRAHYDRO 4 (3 PHENYLUREIDO) 2 QUINOLINECARBOXYLIC ACID; 5,7 DICHLOROKYNURENIC ACID; 6 CHLORO 2 CARBOXYINDOLE 3 ACETIC ACID; 6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; 6,8 DICHLORO 2 (2H) [(3 BROMOPHENYL)METHYL] 1,2,4 BENZOTHIADIAZINE 1,1 DIOXIDE 3 CARBOXYLIC ACID; 7 CHLORO 1,2,5,10 TETRAHYDRO 4 HYDROXY 2 (4 METHOXY 2 METHYLPHENYL)PYRIDAZINO[4,5 B]QUINOLINE 1,10 DIONE; 7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; 7 CHLORO 4 HYDROXY 3 PHENYL 2(1H) QUINOLINONE; ANTICONVULSIVE AGENT; FCE 28833A; GAVESTINEL; GLUTAMATE RECEPTOR; KYNURENIC ACID; KYNURENIC ACID DERIVATIVE; KYNURENINE; L 695902; L 701252; L 705022; NEUROPROTECTIVE AGENT; NICOTINYLALANINE; PNU 156561; PROBENECID; PRODRUG; QUINOLINIC ACID; RPR 104632; SC 49648; UNCLASSIFIED DRUG;

ANTICONVULSANT ACTIVITY; DEGENERATIVE DISEASE; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HUMAN; NEUROPROTECTION; NONHUMAN; REVIEW; SEIZURE; STROKE;

EID: 0034021179     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(00)00121-5     Document Type: Review

References (103)

1. Stone T.W., Perkins M.N. Eur. J. Pharmacol. 72:1981;411-412.
2. Perkins M.N., Stone T.W. Brain Res. 259:1983;172-176.
3. Perkins M.N., Stone T.W. J. Pharmacol. Exp. Ther. 226:1983;551-557.
4. Stone T.W. Br. J. Pharmacol. 81:1984;175-181.
5. Stone T.W. Quinolinic Acid and the Kynurenines. 1989;CRC Press, Boca Raton.
6. Stone T.W. Pharmacol. Rev. 45:1993;309-379.
7. Perkins M.N., Stone T.W. Brain Res. 247:1982;184-187.
8. Stone T.W., Connick J.H. Neuroscience. 15:1985;597-617.
9. Stone T.W., Burton N.R. Prog. Neurobiol. 30:1988;333-368.
10. Johnson J.W., Ascher P. Nature. 325:1987;529-531.
11. Birch P.J., Grossman C.J., Hayes A.G. Eur. J. Pharmacol. 154:1988;85-87.
12. Stone T.W., Perkins M.N. Neurosci. Lett. 52:1984;335-340.
13. Stone T.W. Br. J. Pharmacol. 101:1990;847-852.
14. Brady R.J., Swann J.W. Epilepsy Res. 2:1988;232-238.
15. Stone T.W. Neurosci. Lett. 84:1988;234-238.
16. Scharfman H.E., Goodman J.H. Neuroscience. 86:1998;751-764.
17. Simon R.P., Young R.S.K., Stout S., Cheng J. Neurosci. Lett. 71:1986;361-364.
18. Germano I.M., Pitts L.H., Meldrum B.S., Bartkowski H.M., Simon R.P. Ann. Neurol. 22:1987;730-734.
19. Manallack D.T., Wong M.G., O'Shea R.D., Beart P.M. Neuropharmacology. 1:1990;7-15.
20. Harrison B.L., Baron B.M., Cousino D.M., McDonald I.A. J. Med. Chem. 33:1990;3130-3132.
21. Leeson P.D., Carling R.W., Smith J.D., Baker R., Foster A.C., Kemp J.A. Med. Chem. Res. 1:1991;64-73.
22. Leeson P.D., Baker R., Carling R.W., Curtis N.R., Moore K.W., Williams B.J., et al. J. Med. Chem. 34:1991;1243-1252.
23. Leeson P.D., Carling R.W., Moore K.W., Moseley A.M., Smith J.D., Stevenson G., et al. J. Med. Chem. 35:1992;1954-1968.
24. Leeson P.D., Baker R., Carling R.W., Kulagowski J.J., Mawer I.M., Ridgill M.P., et al. Bioorg. Med. Chem. Lett. 3:1993;299-304.
25. Carling R.W., Leeson P.D., Moseley A.M., Baker R., Foster A.C., Grimwood S., Kemp J.A., Marshall G.R. J. Med. Chem. 35:1992;1942-1953.
26. Carling R.W., Leeson P.D., Moore K.W., Smith J.D., Moyes C.R., Mawer I.M., et al. J. Med. Chem. 36:1993;3397-3408.
27. Bigge C.F. Biochem. Pharmacol. 45:1993;1547-1561.
28. Frey P., Berney D., Herrling P.L., Mueller W., Urwyler S. Neurosci. Lett. 91:1988;194-198.
29. Moroni F., Alesiani N., Galli A., Mori F., Pecorari R., Carla V., Cherici G., Pellicciari R. Eur. J. Pharmacol. 199:1991;227-232.
30. Baron B.M., Harrison B.L., Miller F.P., McDonald I.A., Salituro F.G., Schmidt C.J., et al. Mol. Pharmacol. 38:1990;554-561.
31. Baron B.M., Harrison B.L., McDonald I.A., Meldrum B.S., Palfreyman M.G., Salituro F.G., et al. J. Pharmacol. Exp. Ther. 262:1992;947-956.
32. Foster A.C., Kemp J.A., Leeson P.D., Grimwood S., Donald A.E., Marshall G.R., et al. Mol. Pharmacol. 41:1992;914-922.
33. Foster A.C., Kemp J.A., Tricklebank M.D., Leeson P.D., Carling R.W., Williams B.J., et al. Mol. Neuropharmacol. 2:1992;97-102.
34. Smith E.C.R., McQuaid L.A., Calligaro D.O., O'Malley P.J. Bioorg. Med. Chem. Lett. 3:1993;81-84.
35. McQuaid L.A., Smith E.C.R., South K.K., Mitch C.H., Schoepp D.D., True R.A., et al. J. Med. Chem. 35:1992;3319-3324. 3423-3425.
36. Chapman A.G., Durmuller N., Harrison B.L., Baron B.M., Parvez N., Meldrum B.S. Eur. J. Pharmacol. 274:1995;1-3.
37. Carling R.W., Leeson P.D., Moore K.W., Moyes C.R., Duncton M., Hudson M.L., et al. J. Med. Chem. 40:1997;754-765.
38. Kulagowski J.J., Baker R., Curtis N.R., Leeson P.D., Mawer I.M., Moseley A.M., et al. J. Med. Chem. 37:1994;1402-1405.
39. Sandoz Ltd. (1995) WO9519346.
40. Cai S.X., Zhou Z.L., Huang J.C., Whittemore E.R., Egbuwoku Z.O., Hawkinson J.E., Woodward R.M., Weber E., Keana J.F.W. J. Med. Chem. 39:1996;4682-4686.
41. Salituro F.G., Harrison B.L., Baron B.B., Nyce P.L., Stewart K.T., McDonald I.A. J. Med. Chem. 33:1990;2944-2946.
42. Salituro F.G., Tomlinson R.C., Baron B.B., Demeter D.A., Weintraub H.J.R., McDonald I.A. Bioorg. Med. Chem. Lett. 1:1991;455-460.
43. Salituro F.G., Harrison B.L., Baron B.B., Nyce P.L., Stewart K.T., Kehne J.H., White H.S., McDonald I.A. J. Med. Chem. 35:1992;1791-1799.
44. Gray N.M., Dappen M.S., Cheng B.K., Cordi A.A., Biesterfeldt J.P., Hood W.F., Monahan J.B. J. Med. Chem. 34:1991;1283-1292.
45. Hood W.F., Gray N.M., Dappen M.S., Watson G.B., Compton R.P., Cordi A.A., Lanthorn T.H., Monahan J.B. J. Pharmacol. Exp. Ther. 262:1992;654-660.
46. Rowley M., Leeson P.D., Grimwood S., Foster A., Saywell K. Bioorg. Med. Chem. Lett. 2:1992;1627-1630.
47. Rao T.S., Gray N.M., Dappen M.S., Cler J.A., Mick S.J., Emmett M.R., et al. Neuropharmacology. 32:1993;139-147.
48. Noe C.R., Knollmuller M., Schodl C., Berger M.L. Sci. Pharm. 64:1996;577-590.
49. Glaxo spa. (1993) Patent 2266091.
50. Birch P.J., Grossman C.J., Hayes A.G. Eur. J. Pharmacol. 163:1989;127-131.
51. Leeson P.D., Iversen L.L. J. Med. Chem. 37:1994;4053-4067.
52. Kulagowski J.J. Expert Opin. Therap. Pat. 6:1996;1069-1079.
53. Zeneca Limited (1995) Patent WO9511244.
54. Jimonet P., Audiau F., Aloup J.C., Barreau M., Blanchard J.C., Bohme A., et al. Bioorg. Med. Chem. Lett. 4:1994;2735-2740.
55. Cai S.X., Zhou Z.L., Huang J.C., Whittemore E.R., Egbuwoku Z.O., Lu Y. J. Med. Chem. 39:1996;3248-3255.
56. Keana J.F.W., Kher S.M., Cai S.X., Dinsmore C.M., Glenn A.G., Guastella J. J. Med. Chem. 38:1995;4367-4379.
57. Bristow L.J., Flatman K.L., Hutson P.H., Kulagowski J.J., Leeson P.D., Young L., Tricklebank M.D. J. Pharmacol. Exp. Ther. 277:1996;578-585.
58. Siegel B.W., Sreekrishna K., Baron B.M. Eur. J. Pharmacol. 312:1996;357-365.
59. Merrell Pharmaceuticals (1996) Patent US5519048.
60. Hoechst Marion Roussel (1996) Patent WO9613501.
61. Rhone-Poulenc Rorer (1996) Patent WO9602536.
62. Merck GmbH (1996) Patent EP717044.
63. Jackson P.F., Davenport T.W., Garcia L., McKinney J.A., Melville M.G., Harris G.G., et al. Bioorg. Med. Chem. Lett. 5:1995;3097-3100.
64. Boireau A., Malgouris C., Burgevin M.C. Eur. J. Pharmacol. 300:1996;237-246.
65. Moore L.W., Leeson P.D., Carling R.W., Trickebank M.D., Singh L. Bioorg. Med. Chem. Lett. 3:1993;61-64.
66. Nichols A.C., Yielding K.L. Mol. Chem. Neuropharm. 19:1993;269-282.
67. Hokari M., Wu H.Q., Schwarcz R., Smith Q.R. Neuroreport. 8:1996;15-18.
68. Wood P.L., Hawkinson J.E. Expert Opin. Invest. Drugs. 6:1997;389-397.
69. Lees K.R. Neurology. 49:1997;S66-S69.
70. Dyker A.G., Lees K.R. Stroke. 30:1999;986-992.
71. Connick J.H., Heywood G.C., Sills G.J., Thompson G.G., Brodie M.J., Stone T.W. Gen. Pharmacol. 23:1992;235-239.
72. Russi P., Alesiani M., Lombardi G., Davolio P., Pellicciari R., Moroni F. J. Neurochem. 59:1992;2076-2080.
73. Moroni F., Russi P., Gallo-Mezo M.A., Moneti G., Pellicciari R.J. Neurochem. 57:1991;1630-1635.
74. Pellicciari R., Natalini B., Costantino G., Mahmoud M.R., Mattoli L., Sadeghpour B.M. J. Med. Chem. 37:1994;647-655.
75. Varasi M., Della Torre A., Heidempergher F., Pevarello P., Speciale C., Guidetti P., Wells D.R., Schwarcz R. Eur. J. Med. Chem. 31:1996;11-21.
76. Harris C.A., Miranda A.F., Tanguay J.J., Boegman R.J., Beninger R.J., Jhamandas K. Br. J. Pharmacol. 124:1998;391-399.
77. Natalini B., Mattoli L., Pellicciari R., Carpenedo R., Chiarugi A., Moroni F. Bioorg. Med. Chem. Lett. 5:1995;1451-1454.
78. Chiarugi A., Carpenedo R., Molina M.T., Mattoli L., Pellicciari R., Moroni F. J. Neurochem. 65:1995;1176-1183.
79. Chiarugi A., Carpenedo R., Moroni F.J. Neurochem. 67:1996;692-698.
80. Speciale C., Wu H.Q., Cini M., Marconi M., Varasi M., Schwarcz R. Eur. J. Pharmacol. 315:1996;263-267.
81. Rover S., Cesura A.M., Hugenin P., Kettler R., Szente A. J. Med. Chem. 40:1997;4378-4385.
82. Walsh J.L., Todd W.P., Carpenter B.K., Schwarcz R. Biochem. Pharmacol. 42:1991;985-990.
83. Heyes M.P., Hutto B., Markey S.P. Neurochem. Int. 13:1988;405-408.
84. Walsh J.L., Wu H.Q., Ungerstedt U., Schwarcz R. Brain Res. Bull. 33:1994;513-516.
85. Naritsin D.B., Saito K., Markey S.P., Heyes M.P. J. Neurochem. 65:1995;2217-2226.
86. Kulagowski B.D., Leeson P.D. Expert Opin. Therap. Pat. 5:1995;1061-1075.
87. Warner D.S., Martin H., Ludwig P., McAllister A., Keana J.F.W., Weber E. J. Cereb. Blood Flow Metab. 15:1995;188-196.
88. Priestley T., Laughton P., Macaulay A.J., Hill R.G., Kemp J.A. Neuropharmacology. 35:1996;1573-1581.
89. Ilyin V.I., Whittemore E.R., Tran M., Shen K.Z., Cai S.X., Kher S.M., et al. Eur. J. Pharmacol. 310:1996;107-114.
90. Kretschmer B.D., Kratzer U., Breithecker K., Koch M. Eur. J. Pharmacol. 331:1997;109-116.
91. Wood P.L., Hawkinson J.E. Expert Opin. Invest. Drugs. 6:1997;389-397.
92. Hawkinson J.E., Huber K.R., Sahota P.S., Hsu H.H., Weber E., Whitehouse M.J. Brain Res. 744:1997;227-234.
93. Lipton S.A. Annu. Rev. Pharmacol. Toxicol. 38:1998;159-177.
94. Wood E.R., Bussey T.J., Phillips A.G. Neurosci. Lett. 145:1992;10-14.
95. Takano K., Tatlisumak M.T., Formato J.E., Carano R.A.D., Bergmann A.G., Pullan L.M. Stroke. 28:1997;1255-1263.
96. Heyes M.P., Rubinow D., Lane C., Markey S.P. Ann. Neurol. 26:1989;275-277.
97. Heyes M.P., Mefford I.N., Quearry B.J., Dedhia M., Lackner A. Ann. Neurol. 27:1990;666-675.
98. Ishimaru M., Kurumaji A., Ross C.A., Pearlson G.D. Biol. Psychiatry. 32:1992;379-380.
99. Ishimaru M., Kurumaji A., Toru M. Life Sci. 55:1994;1683-1699.
100. Ishimaru M., Kurumaji A., Toru M., Ross C.A., Pearlson G.D. Trends Neurosci. 19:1996;416-417.
101. Tamminga C.A. Crit. Rev. Neurobiol. 12:1998;21-36.
102. Costa J., Khaled E., Sramek J., Bunney W.E., Potkin S. Clin. Psychopharmacol. 10:1990;71-72.
103. Hutson P.H., Bristow L.J., Thorn L., Tricklebank M.D. Br. J. Pharmacol. 103:1991;2037-2044.